Cargando…
Influence of the Molar Activity of (203/212)Pb-PSC-PEG(2)-TOC on Somatostatin Receptor Type 2-Binding and Cell Uptake
(1) Background: In neuroendocrine tumors (NETs), somatostatin receptor subtype 2 is highly expressed, which can be targeted by a radioactive ligand such as [(177)Lu]Lu-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid-[Tyr(3),Thr(8)]-octreotide ((177)Lu-DOTA-TOC) and, more recently, by a le...
Autores principales: | Pretze, Marc, Michler, Enrico, Runge, Roswitha, Wetzig, Kerstin, Tietze, Katja, Brandt, Florian, Schultz, Michael K., Kotzerke, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10675797/ https://www.ncbi.nlm.nih.gov/pubmed/38004470 http://dx.doi.org/10.3390/ph16111605 |
Ejemplares similares
-
Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for (203)Pb and (212)Pb-Based Theranostics
por: Li, Mengshi, et al.
Publicado: (2023) -
Ac-EAZY! Towards GMP-Compliant Module Syntheses of (225)Ac-Labeled Peptides for Clinical Application
por: Pretze, Marc, et al.
Publicado: (2021) -
Production, purification, and radiolabeling of the (203)Pb/(212)Pb theranostic pair
por: McNeil, Brooke L., et al.
Publicado: (2021) -
TOC
Publicado: (2020) -
TOC
Publicado: (2020)